Visitors and news

During the ASCCP XXVI scientific meeting 2019, Professor Walter Prendiville, Senior Visiting Scientist at the IARC Screening Group, presented the effective innovations in low and middle-income countries (screening, triage and treatment) and the findings of the Zambian study: “Randomized controlled trial of the Liger Thermal Coagulator versus cryosurgery and versus large loop excision of the transformation zone (LLETZ) to prevent cervical neoplasia in VIA-positive women in low- and middle-income countries”.

Dr Partha Basu will be talking the 2 April at 16:00 CET about the timely topic of cervical cancer prevention (Recommendations of the European Code Against Cancer, Towards elimination of cervical cancer: WHO call to action, State of play in Europe: screening & vaccination and Global impact of cervical cancer prevention) within the framework of the association of the European Cancer Leagues (ECL) and the European Code Against Cancer (ECAC). The webinar is open for registration: Registration for the webinar.

The Screening Group is delighted to present the findings of this study which aimed to examine the development indicators that are correlated with cervical cancer mortality in Brazil. The results of the present study can help to better monitor the quality assessment of cervical cancer programs both among and within countries.
View the article.

Our Group and collaborators recently published a paper about the increasing incidence of cervical cancer in young Japanese women. This trend was not observed among Japanese-American and South Korean women, for the same period of time (1985-2012). These findings are likely to be attributable to increasing prevalence of human papillomavirus (HPV) infection among young women, and they emphasize urgent need for effective cancer control programs including resuming pro-active recommendation of the HPV vaccination and improving cervical cancer screening in Japan. View the article.

Professor Ashrafun Nessa, Bangabandhu Sheikh Mujib Medical University Hospital, Bangladesh, has been the focal point of the Cervical and Breast Cancer Screening Programme of the Government of Bangladesh since 2004, helping to develop screening and colposcopy clinics with support of the Screening Group.
Watch video.

IARC Director Dr Elisabete Weiderpass visited the Serum Institute of India in Pune, and discussed the IARC-coordinated HPV vaccine trials in Pune with Dr Rengaswamy Sankaranarayanan, IARC Senior Visiting Scientist, Dr Partha Basu, Head of the IARC Screening Group and Dr Smita Joshi principal investigator of the Pune site.

Dr Partha Basu and Dr Srabani Mittal conducted this practical training course to train the trainers within the framework of the project “Diagnostic test accuracy of the low-cost portable magnifying device mobile colposcope in HIV-positive women in Zambia” in collaboration with the Department of Reproductive, Maternal, Newborn, and Child Health at the Centre for Infectious Disease Research in Zambia (CIDRZ), and the Institute of Social and Preventive Medicine (ISPM), Switzerland.

Dr Partha Basu visited the Delta office in the Centre for Infectious Disease Research to discuss the progress with the local team of the ongoing United States National Cancer Institute-funded project “Randomized controlled trial of the Liger Thermal Coagulator versus cryosurgery and versus large loop excision of the transformation zone (LLETZ) to prevent cervical neoplasia in VIA-positive women in low- and middle-income countries”.

Dr Rengaswamy Sankaranarayanan, former Screening Group head, discussed about the new Indian National Cancer Control Plan (NCCP), about the complexity of cancer care and the way forward.
Watch video.

Dr Sauvaget and colleagues described a breast cancer awareness project in an urban community in Mumbai, India. This exploratory study revealed that awareness-based screening programmes with organised infrastructure and referral pattern could lead to diagnosing early cancers.
View the article.